FDA Approves FRUZAQLA (Fruquintinib) in Refractory Metastatic Colorectal Cancer

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217564s000lbl.pdf?utm_medium=email&utm_source=govdelivery